In this issue of the Scandinavian Journal of Pain, Fischer and coworkers  review several methods available for objective measurement of the central nervous system (CNS) effects of opioids and opioid induced analgesia, both at the spinal and the supraspinal levels. This is an important issue as objective, quantifiable markers for opioid analgesia would be of utmost importance both in basic research and drug development, as well as in the assessment of therapeutic efficacy and drug resistant pain conditions in the clinic. Nevertheless, clinical trials mostly rely on subjective reports on the pain estimated with visual analogue scale (VAS) or numerical rating scale (NRS). The task to reduce the subjective, multidimensional experience of pain to objective biomarkers is challenging. This review  ambitiously tackles the problem showing many potential tools already available for the assessment of central nervous system effects of opioids and their relationship to analgesia but, simultaneously, it highlights the problems and open questions in the field.1The methods available for objective assessment of opioid effectsPupillometry seems to be a reliable and feasible measure to assess central opioid effects even on the chair-side as the authors have previously shown . However, as the pupillary size is controlled by
Scandinavian Journal of Pain – de Gruyter
Published: Jan 1, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud